“Not just another meta‐analysis”: Sources of heterogeneity in psychosocial treatment effect on cancer survival
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Background: Currently, there are eight meta‐analyses that address the question whether psychosocial intervention can prolong survival with widely disparate conclusions. One reason for inconsistent findings may be the methods by which previous meta‐analyses were conducted. Methods: Databases were searched to identify valid randomized controlled trials that compared psychosocial intervention with usual care. Hazard ratios (HRs) and their confidence intervals were pooled to estimate the strength of the treatment effect on survival time, and z‐tests were performed to assess possible heterogeneity of effect sizes associated with different patient and treatment characteristics. Results: Twelve trials involving 2439 cancer patients that met screening criteria were included. The overall effect favored the treatment group with a HR of 0.71 (95% Cl 0.58‐0.88; P = 0.002). An effect size favoring treatment group was observed in studies sampling lower vs higher percentage of married patients’ (NNT = 4.3 vs NNT = 15.4), when Cognitive‐Behavioral Therapy was applied at early vs late cancer stage (NNT = 2.3 vs NNT = −28.6), and among patients’ older vs younger than 50 (NNT = 4.2 vs NNT = −20.5). Conclusions: Psychosocial interventions may have an important effect on survival. Reviewed interventions appear to be more effective in unmarried patients, patients who are older, and those with an early cancer stage who attend CBT. Limitations of previous meta‐analysis are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000678 · Cited by 7,482 · cited 3×
“…Cl) NNT Weight Stagl (2015) – 1.56 (–3.05, –0.07) 1.53 1.3% McCorkle (2000) – 0.71 (–1.14, –0.27) 2.92 14.7% Spiegel (1989) – 0.67 (–1.17, –0.18) 3.10 11.6% Temel (2010) – 0.54 (–0.92, –0.15) 3.76 19.3% Bakitas (2009) – 0.40 (–0.70, –0.10) 5.06 23.6% Ross (2009) – 0.39 (–0.86, 0.09) 5.25 12.5%…”
InfluentialPractical methods for incorporating summary time-to-event data into meta-analysis.
Tierney, J. F., Stewart, L. A., Ghersi, D., Burdett, S., & Sydes, M. R. (2007) · Trials · doi:10.1186/1745-6215-8-16 · Cited by 6,208
EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER
Spiegel, D., Kraemer, H., Bloom, J., & Gottheil, E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91551-1 · Cited by 2,353
Self-citationBakitas, M., Lyons, K. D., Hegel, M. T., Balan, S., Brokaw, F. C., Seville, J., Hull, J. G., Li, Z., Tosteson, T. D., Byock, I. R., et al. (2009) · JAMA · doi:10.1001/jama.2009.1198 · Cited by 1,726 · cited 3×
“…–0.07) 1.53 1.3% McCorkle (2000) – 0.71 (–1.14, –0.27) 2.92 14.7% Spiegel (1989) – 0.67 (–1.17, –0.18) 3.10 11.6% Temel (2010) – 0.54 (–0.92, –0.15) 3.76 19.3% Bakitas (2009) – 0.40 (–0.70, –0.10) 5.06 23.6% Ross (2009) – 0.39 (–0.86, 0.09) 5.25 12.5% Spiegel (2007) – 0.07 (–0.47, 0.34) 27.57…”
InfluentialSystematic Review: Why sources of heterogeneity in meta-analysis should be investigated
Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.309.6965.1351 · Cited by 1,017
Faller, H., Schuler, M., Richard, M., Heckl, U., Weis, J., & Küffner, R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.8922 · Cited by 912
The Effect of Group Psychosocial Support on Survival in Metastatic Breast Cancer
Goodwin, P. J., Leszcz, M., Ennis, M., Koopmans, J., Vincent, L., Guther, H., Drysdale, E., Hundleby, M., Chochinov, H. M., Navarro, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011871 · Cited by 891 · cited 3×
“– 0.15) 2.57 7.0% Kuchler (2007) –0.37 (–0.66, – 0.08) 5.45 39.0% Cunningham (1998) –0.27 (–0.84, 0.30) 7.30 9.9% Goodwin (2001) 0.21 (–0.13, 0.54) –9.70 28.5% Edelman (1999) 0.28 (–0.17, 0.73) –7.25 15.7% Total –0.13 (–0.31; 0.05) 15.41 100% Group differences statistics z value: P=0.005 B CBT in…”
InfluentialCalculating the number needed to treat for trials where the outcome is time to an event
Altman, D. G., & Andersen, P. K. (1999) · BMJ · doi:10.1136/bmj.319.7223.1492 · Cited by 710
Meyer, T. J., & Mark, M. M. (1995) · Health Psychology · doi:10.1037/0278-6133.14.2.101 · Cited by 689
Cited by
Wang, X., Wang, N., Zhong, L., Wang, S., Zheng, Y., Yang, B., Zhang, J., Lin, Y., & Wang, Z. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00865-6 · Cited by 512
Stress and cancer: mechanisms, significance and future directions
Eckerling, A., Ricon-Becker, I., Sorski, L., Sandbank, E., & Ben-Eliyahu, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00395-5 · Cited by 348
Antoni, M. H., Moreno, P. I., & Penedo, F. J. (2023) · Annual Review of Psychology · doi:10.1146/annurev-psych-030122-124119 · Cited by 132
“Based upon recent meta-analyses, it appears that CBT-based SMI approaches are particularly effective, but more so in patients with earlier, nonmetastatic disease, in particular breast cancer (Mirosevic et al. 2019).”
BackgroundMethodResultInfluentialStress and coping in women with breast cancer:unravelling the mechanisms to improve resilience
Borgi, M., Collacchi, B., Ortona, E., & Cirulli, F. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.011 · Cited by 90
Teahan, Á., Lafferty, A., McAuliffe, E., Phelan, A., O’Sullivan, L., O’Shea, D., Nicholson, E., & Fealy, G. (2020) · Journal of Aging and Health · doi:10.1177/0898264319899793 · Cited by 85
“…demographic and clinical characteristics, such as age, marital status, disease type, should be considered alongside intervention characteristics, such as intervention type, format, frequency, and duration, to account for heterogeneity prior to wide-scale implementation (Mirosevic et al., 2019).”
Background
Metadata
- Authors
- Mirosevic, S., Jo, B., Kraemer, H. C., Ershadi, M., Neri, E., & Spiegel, D.
- Venue
- Cancer Medicine
- Publisher
- Wiley
- Published
- 2019-01
- Volume
- 8
- Issue
- 1
- Pages
- 363-373
- ISSN
- 2045-7634 (ISSN-L)
- OpenAlex
- W2906838986
- Cited by
- 60
- References
- 16
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.